Eca-109 Cells

Eca-109 is a human esophageal squamous cell carcinoma (ESCC) cell line that is widely used for cancer research, particularly studies focusing on tumor progression, cell migration, and apoptosis. This cell line provides a representative model for esophageal cancer, which is a significant health concern with a high mortality rate due to aggressive progression and poor prognosis. In research involving Eca-109 cells, several critical pathways have been studied. For instance, the modulation of autophagy has been shown to influence radiosensitivity. Inhibition of autophagy in Eca-109 cells, using agents such as 3-methyladenine (3-MA) or LY294002, has been demonstrated to enhance the cytotoxic effects of ionizing radiation by promoting apoptosis through mitochondrial pathways, including cytochrome c release and caspase activation. Furthermore, studies have highlighted the role of the EGFR/ERK1/2 signaling pathway in promoting migration and invasiveness of these cells, with findings that EGF stimulation increases aquaporin-8 (AQP8) expression, facilitating cell migration. Another significant aspect of Eca-109 research is the exploration of therapeutic targets, such as galectin-3. Overexpression of this protein in Eca-109 cells has been associated with enhanced cell proliferation, migration, and invasion, while concurrently reducing apoptosis, indicating its potential as a molecular target for treatment.